Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Metabolic perturbance in autism spectrum disorders: a metabolomics study.

Ming X, Stein TP, Barnes V, Rhodes N, Guo L.

J Proteome Res. 2012 Dec 7;11(12):5856-62. doi: 10.1021/pr300910n. Epub 2012 Nov 9.

2.

Metabolomics characterization of energy metabolism reveals glycogen accumulation in gut-microbiota-lacking mice.

Chuang HL, Huang YT, Chiu CC, Liao CD, Hsu FL, Huang CC, Hou CC.

J Nutr Biochem. 2012 Jul;23(7):752-8. doi: 10.1016/j.jnutbio.2011.03.019. Epub 2011 Aug 12.

PMID:
21840188
3.

1H-13C NMR-based urine metabolic profiling in autism spectrum disorders.

Mavel S, Nadal-Desbarats L, Blasco H, Bonnet-Brilhault F, Barthélémy C, Montigny F, Sarda P, Laumonnier F, Vourc'h P, Andres CR, Emond P.

Talanta. 2013 Sep 30;114:95-102. doi: 10.1016/j.talanta.2013.03.064. Epub 2013 Apr 9.

4.

The footprints of gut microbial-mammalian co-metabolism.

Zheng X, Xie G, Zhao A, Zhao L, Yao C, Chiu NH, Zhou Z, Bao Y, Jia W, Nicholson JK, Jia W.

J Proteome Res. 2011 Dec 2;10(12):5512-22. doi: 10.1021/pr2007945. Epub 2011 Oct 24.

PMID:
21970572
5.

Gut permeability in autism spectrum disorders.

Dalton N, Chandler S, Turner C, Charman T, Pickles A, Loucas T, Simonoff E, Sullivan P, Baird G.

Autism Res. 2014 Jun;7(3):305-13. doi: 10.1002/aur.1350. Epub 2013 Dec 12.

6.

Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms?

Wang L, Angley MT, Gerber JP, Young RL, Abarno DV, McKinnon RA, Sorich MJ.

Biomarkers. 2009 Dec;14(8):596-603. doi: 10.3109/13547500903183962.

PMID:
19697973
7.

The urinary metabolomics profile of an Italian autistic children population and their unaffected siblings.

Noto A, Fanos V, Barberini L, Grapov D, Fattuoni C, Zaffanello M, Casanova A, Fenu G, De Giacomo A, De Angelis M, Moretti C, Papoff P, Ditonno R, Francavilla R.

J Matern Fetal Neonatal Med. 2014 Oct;27 Suppl 2:46-52. doi: 10.3109/14767058.2014.954784.

PMID:
25284177
8.

Combined 1H-NMR and 1H-13C HSQC-NMR to improve urinary screening in autism spectrum disorders.

Nadal-Desbarats L, Aïdoud N, Emond P, Blasco H, Filipiak I, Sarda P, Bonnet-Brilhault F, Mavel S, Andres CR.

Analyst. 2014 Jul 7;139(13):3460-8. doi: 10.1039/c4an00552j.

PMID:
24841505
9.

Metabolomics approaches for characterizing metabolic interactions between host and its commensal microbes.

Xie G, Zhang S, Zheng X, Jia W.

Electrophoresis. 2013 Oct;34(19):2787-98. doi: 10.1002/elps.201300017. Epub 2013 Aug 16. Review.

PMID:
23775228
10.

Metabolomics Study of Urine in Autism Spectrum Disorders Using a Multiplatform Analytical Methodology.

Diémé B, Mavel S, Blasco H, Tripi G, Bonnet-Brilhault F, Malvy J, Bocca C, Andres CR, Nadal-Desbarats L, Emond P.

J Proteome Res. 2015 Dec 4;14(12):5273-82. doi: 10.1021/acs.jproteome.5b00699. Epub 2015 Nov 23.

PMID:
26538324
11.

Urinary metabolic phenotyping differentiates children with autism from their unaffected siblings and age-matched controls.

Yap IK, Angley M, Veselkov KA, Holmes E, Lindon JC, Nicholson JK.

J Proteome Res. 2010 Jun 4;9(6):2996-3004. doi: 10.1021/pr901188e.

PMID:
20337404
12.

Altered metabolites in the plasma of autism spectrum disorder: a capillary electrophoresis time-of-flight mass spectroscopy study.

Kuwabara H, Yamasue H, Koike S, Inoue H, Kawakubo Y, Kuroda M, Takano Y, Iwashiro N, Natsubori T, Aoki Y, Kano Y, Kasai K.

PLoS One. 2013 Sep 18;8(9):e73814. doi: 10.1371/journal.pone.0073814. eCollection 2013.

13.

Is there a role for routinely screening children with autism spectrum disorder for creatine deficiency syndrome?

Wang L, Angley MT, Sorich MJ, Young RL, McKinnon RA, Gerber JP.

Autism Res. 2010 Oct;3(5):268-72. doi: 10.1002/aur.145.

PMID:
20589913
14.

GC-MS-based urine metabolic profiling of autism spectrum disorders.

Emond P, Mavel S, Aïdoud N, Nadal-Desbarats L, Montigny F, Bonnet-Brilhault F, Barthélémy C, Merten M, Sarda P, Laumonnier F, Vourc'h P, Blasco H, Andres CR.

Anal Bioanal Chem. 2013 Jun;405(15):5291-300. doi: 10.1007/s00216-013-6934-x. Epub 2013 Apr 10.

15.

Gut microbial activity, implications for health and disease: the potential role of metabolite analysis.

Nyangale EP, Mottram DS, Gibson GR.

J Proteome Res. 2012 Dec 7;11(12):5573-85. doi: 10.1021/pr300637d. Epub 2012 Nov 1. Review.

PMID:
23116228
16.

Abnormal transsulfuration metabolism and reduced antioxidant capacity in Chinese children with autism spectrum disorders.

Han Y, Xi QQ, Dai W, Yang SH, Gao L, Su YY, Zhang X.

Int J Dev Neurosci. 2015 Nov;46:27-32. doi: 10.1016/j.ijdevneu.2015.06.006. Epub 2015 Jul 3.

PMID:
26150135
17.

The prevalence of gastrointestinal problems in children across the United States with autism spectrum disorders from families with multiple affected members.

Wang LW, Tancredi DJ, Thomas DW.

J Dev Behav Pediatr. 2011 Jun;32(5):351-60. doi: 10.1097/DBP.0b013e31821bd06a.

PMID:
21555957
18.

Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder.

Wang L, Christophersen CT, Sorich MJ, Gerber JP, Angley MT, Conlon MA.

Dig Dis Sci. 2012 Aug;57(8):2096-102. doi: 10.1007/s10620-012-2167-7. Epub 2012 Apr 26.

PMID:
22535281
19.

Evaluating effects of penicillin treatment on the metabolome of rats.

Sun J, Schnackenberg LK, Khare S, Yang X, Greenhaw J, Salminen W, Mendrick DL, Beger RD.

J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Aug 1;932:134-43. doi: 10.1016/j.jchromb.2013.05.030. Epub 2013 Jun 7.

PMID:
23831706
20.

Study of plasma metabolic profiling and biomarkers of chronic unpredictable mild stress rats based on gas chromatography/mass spectrometry.

Li ZY, Zheng XY, Gao XX, Zhou YZ, Sun HF, Zhang LZ, Guo XQ, Du GH, Qin XM.

Rapid Commun Mass Spectrom. 2010 Dec 30;24(24):3539-46. doi: 10.1002/rcm.4809.

PMID:
21080506

Supplemental Content

Support Center